Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Creatine in treated Parkinson's disease (NET-PD LS-1)
NCT00449865Phase 3Terminated
- Sponsor
- University of Rochester
- Start
- Mar 2007
- Primary completion
- Sep 2013
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of creatine in Parkinson's disease (PD), sponsored by University of Rochester. Started Mar 2007; status: terminated.
02
Drugs
creatine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00449865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00449865.